Future Medicine India – Cover Story, Medical Research News Cover Story Archives | Future Medicine India

Cover Story

The new normal

India eases stay-at-home measures even as fresh cases of COVID-19 hit new highs every day

S Harachand
Read More..

Contagion engulfs Mumbai’s slums

Mumbai, the fulcrum of India’s economic activity, has been the worst-hit in the country, accounting for 20 percent of the country’s total coronavirus infections and nearly 25 percent of the deaths.


“HVTN trials aim to describe immune response in people recovered from SARS-CoV-2 infection’

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network. Based at the Nobel laureates-driven Fred Hutchinson Cancer Research Center and funded by NIH, HVTN joined the COVID-19 response by initiating their first clinical trial.


Immunity passports: A tool of discrimination and inequity?

Governments are now thinking of introducing ‘immunity passports’ to those who have recovered and tested positive for antibodies to SARS-CoV-2 in an effort to reverse the catastrophic economic impact of the COVID-19 pandemic.


Viral genome sequence data to diffuse a second wave

Even as countries around the world expect a second wave of COVID-19 infections with the easing of lockdown measures, researchers are planning to exploit the pathogen’s genome sequencing information to avert such a possibility.


COVID-19 wreaks global havoc with breath-taking fury

Luc Montagnier, who received the Nobel Prize for Physiology or Medicine in 2008 for the discovery of HIV, shocked the world recently with his announcement that the novel coronavirus genome has elements of the HIV-1 retrovirus, suggesting that it could well be man-made, possibly as part of an effort to develop an AIDS vaccine.

S Harachand

COVID-19 vax makers fear immune ‘back firing’

With 79 vaccines currently under development worldwide to combat COVID-19, researchers are trying to obviate a potential but dangerous obstacle: immune enhancement.